miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
2019 ◽
Vol 35
(1)
◽
pp. 17-23
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 12
(02)
◽
Keyword(s):
2017 ◽